Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29801223 | 0.70 | ALDH1A1 (0.42) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL5101469 | 0.70 | KDM4E (0.54) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL31001160 | 0.69 | ALDH1A1 (0.46) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL5417047 | 0.69 | RAB9A (0.40) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL31040367 | 0.66 | IDO1 (0.37) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL10598338 | 0.65 | CYP1A2 (0.37) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL6691319 | 0.64 | ALDH1A1 (0.55) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL10396387 | 0.64 | ELANE (0.35) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL29633947 | 0.64 | GPR3 (0.42) | ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL2492556 | 0.63 | ALDH1A1 (0.62) | ALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10179768-B2 | Electrochromic two-core viologen derivatives and optical articles containing them | ESSILOR INTERNATIONAL (FR) | 2019-01-15 | — | — | US | disclosed |
| EP-2848668-B1 | Electrochromic two-core viologen derivatives and optical articles containing them | ESSILOR INT (FR) | 2019-01-09 | — | — | EP | disclosed |
| US-20160221949-A1 | ELECTROCHROMIC TWO-CORE VIOLOGEN DERIVATIVES AND OPTICAL ARTICLES CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQU E) (FR) | 2016-08-04 | — | — | US | disclosed |
| WO-2015040031-A1 | ELECTROCHROMIC TWO-CORE VIOLOGEN DERIVATIVES AND OPTICAL ARTICLES CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2015-03-26 | — | — | WO | disclosed |
| EP-2848668-A1 | Electrochromic two-core viologen derivatives and optical articles containing them | ESSILOR INTERNATIONAL (Compagnie Générale d'Optique) (FR) | 2015-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160221949-A1 | ELECTROCHROMIC TWO-CORE VIOLOGEN DERIVATIVES AND OPTICAL ARTICLES CONTAINING THEM | EYA2, CRY2, PPOX | ALDH1A1 2634/4885HPGD 443/4885SMN1; SMN2 4767/4885 |
| US-10179768-B2 | Electrochromic two-core viologen derivatives and optical articles containing them | EYA2, CRY2, PPOX | ALDH1A1 2634/4885HPGD 443/4885SMN1; SMN2 4767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.